4-(1,3,4-Oxadiazol-2-yl)pyridine, 95+%, 1g

(2R,3R,4R,5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 98%, 250mg

tert-Butyl (5-formylpyridin-2-yl)carbamate, 95.0%, 100mg

Vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated cSt 250-350, 100g

TERT-BUTYL (2S)-2-CYCLOPROPYLPIPERAZINE-1-CARBOXYLATE, 95.0%, 1g

1-(3,5-Dimethylphenyl)cyclopropanamine hydrochloride, 100mg

2-Methoxynicotinonitrile, 97.0%, 1g

4-BROMO-2,7-DIMETHYL-2H-INDAZOLE, 95.0%, 250mg

O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, 98.0%, 5g

6-Chloro-1-methyl-2,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95%, 1g

4-(Dimethylamino)benzhydrazide, 98.0%, 1g

(S)-5-Bromomethyl-2-oxopyrrolidine, 95.0%, 5g

3-Nitropicolinaldehyde, 95.0%, 5g